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SUMMARY
The C. elegans vulva is patterned by epidermal growth factor (EGF) activation of Ras to control
1° fate, and 1° fate induces antagonistic Notch-dependent 2° fate. Furthermore, a spatial EGF
gradient, in addition to inducing 1° fate, directly contributes to 2° fate via an unknown pathway.
We find that in addition to its canonical effector, Raf, vulval Ras utilizes an exchange factor for
the Ral small GTPase (RalGEF), such that Ras-RalGEF-Ral antagonizes Ras-Raf pro-1° fate
activity. Consistent with its restricted expression pattern, Ral participates in EGF pro-2° activity.
Thus, we have delineated a Ras effector-switching mechanism whereby position within the
morphogen gradient dictates that Ras effector usage is switched to RalGEF from Raf to promote
2° instead of 1° fate. Our observations define the utility of Ras effector switching during normal
development, and may provide a possible mechanistic basis for cell and cancer type differences in
effector dependency and activation.
INTRODUCTION
An emerging complexity of mammalian Ras signal transduction is the assortment of
catalytically diverse effectors that may facilitate the elaborate biological activities of Ras in
normal and neoplastic cells. The precise role that each effector serves, dynamic regulation of
effector utilization, and interplay between effector networks are issues that remain poorly
understood. Analysis of C. elegans vulval development has provided key insights into Ras
signaling components and concepts conserved in mammalian cells. The vulval precursor
cells (VPCs) are a developmental equivalence group of six ventral epithelial cells (P3.p–
P8.p) (Sternberg, 2005) (Figure 1A). The nearby anchor cell (AC) induces VPCs to assume
a highly reproducible 3°-3°-2°-1°-2°-3° pattern of fates. The AC-proximal VPC is induced
to assume the 1° fate, flanking VPCs assume the 2° fate, and distal uninduced VPCs assume
the non-vulval 3° fate.
Along with studies in other systems, analyses of the pro-1° AC inductive signal were
instrumental in delineating the first signal transduction pathway connecting the cell surface
to the nucleus (Egan and Weinberg, 1993). The AC secretes LIN-3/EGF (epidermal growth
factor), which promotes LET-60/Ras activation of the LIN-45/Raf-MEK-ERK mitogen-
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activated protein kinase (MAPK) signaling cascade to regulate the LIN-1 (Ets) and LIN-31
(HNF) transcription factors, thereby inducing 1° fate (Sundaram, 2006) (Figure 1B).
Analogously to human cancers, mutational activation of LET-60/Ras promotes ERK
activation, leading to excess vulval induction (Figures 2A and 2B), while loss of pathway
components results in vulval absence. All constituents of this signaling pathway, particularly
LET-60/Ras, are strongly conserved (Figure S1C). This degree of conservation argued,
prematurely, that our understanding of Ras effector signaling was complete. However,
subsequent mammalian cell studies characterized additional Ras effectors, with now at least
10 distinct functional classes identified (Repasky et al., 2004). With many effectors
expressed ubiquitously, an unresolved issue is how Ras effector utilization is orchestrated to
facilitate the complex biological outputs of Ras.
Recent analyses have implicated the guanine nucleotide exchange factor for the Ral GTPase
(RalGEF) as an effector of importance comparable to Raf in Ras-dependent human
oncogenesis (Chien and White, 2003; Hamad et al., 2002). Like Ras, Ral functions as a
GDP/GTP-regulated switch. Since RalGEF and Ral are conserved in C. elegans, EGF
activation of Ras could involve the RalGEF-Ral pathway in regulation of vulval cell fate.
Two competing models have been proposed to illustrate the mechanisms of vulval fate
patterning. The original “morphogen gradient model” posits that a LIN-3/EGF, AC-maximal
concentration gradient differentially patterns VPCs dictated by proximity to the AC (Katz et
al., 1995; Katz et al., 1996; Sternberg and Horvitz, 1986, 1989). This model posits that while
strong EGF signal induces 1° fate, diminished EGF signal directly promotes 2° fate for more
distal VPCs. Appropriately, an ERK-responsive 1° fate reporter was highly expressed in the
presumptive 1° VPC, with transient low expression in presumptive 2° VPCs (Yoo et al.,
2004), but further mechanistic support is lacking.
In contrast, the “sequential induction model” proposes that EGF induces only the most
proximal VPC, which becomes 1°. Subsequently this presumptive 1° cell expresses DSL
ligands that, via the LIN-12/Notch receptor, laterally induce neighboring VPCs to assume 2°
fate (Chen and Greenwald, 2004). Accordingly, the LET-23/EGF receptor (EGFR) is
necessary for 1° but not 2° fate induction (Koga and Ohshima, 1995; Simske and Kim,
1995), and pro-1° EGF and pro-2° Notch pathways together are necessary and sufficient to
generate initial commitment to the 2°-1°-2° fate pattern (Greenwald, 2005; Sternberg, 2005).
However, the “sequential induction model” and the “morphogen gradient model” have yet to
be mechanistically reconciled.
Importantly, 1° and 2° fates are mutually antagonistic; via “quenching” mechanisms
inappropriate pathway activities are reduced to minimize conflicting pro-1° and pro-2°
signals in the same cell. Presumptive 1° cells enact programs that antagonize pro-2°
signaling (Levitan and Greenwald, 1998; Yoo and Greenwald, 2005), and conversely
presumptive 2° cells enact programs that antagonize pro-1° signaling (Berset et al., 2001;
Berset et al., 2005; Yoo et al., 2004). For example, the LIP-1 ERK protein phosphatase is
expressed in presumptive 2° lineages to quench ERK signaling. Thus, the developmental
consequences of EGF activation of Ras-Raf signaling in 2° lineages may be minimal, and
pro-2° EGF activity mediated through distinct effector pathways.
The most plausible composite model for robust vulval patterning would be one that
reconciles these three evidence-based models: graded morphogen signaling, sequential
induction, and pathway quenching. Yet nothing is known about the mechanism of the
putative pro-2° EGF signal. Despite decades of research into how a single morphogen
gradient can induce multiple cell fates, there are few instances in which the mechanism of
such differential inductions is understood (Piddini and Vincent, 2009).
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In this study, we identify a mechanism for EGF pro-2° signaling and thus reconcile the three
features of vulval patterning into a unified model. We show that during vulval patterning
Ras through Raf transduces a pro-1° signal, then through the RalGEF-Ral pathway
transduces a pro-2° signal. Ral signaling antagonizes Raf and regulates the balance of 1° and
2° fates. Ral is necessary and sufficient to drive maximal Notch pro-2° activity, and the
RalGEF-Ral pathway is quenched in presumptive 1° cells by restricted Ral expression. In
summary, our study establishes that Ras effector utilization is controlled to signal for
distinct cellular outcomes. Analogous mechanisms may therefore contribute to the distinct
patterns of effector utilization that occur in different settings of mutant Ras-driven human
cancers.
RESULTS
C. elegans Contains Single RalGEF and Ral Orthologs
The C. elegans genome contains single RalGEF (rgl-1; F28B4.2) and Ral (ral-1; Y53G8AR.
3) genes. rgl-1 encodes predicted splice variants producing proteins of 860 and 880 residues
that share the identical domain architecture with human Ras-GTP Association (RA) domain-
containing RalGEFs: an N-terminal Ras Exchange Motif (REM), a central CDC25
homology (RasGEF) catalytic domain, and a C-terminal RA domain (Figure S1A). ral-1
encodes a predicted protein of 213 residues consisting of a GTPase domain and C-terminal
membrane-targeting sequence sharing strong sequence identity (61–65%) with human RalA
and RalB (Figures 1C and S1B). The effector binding regions of human and C. elegans Ral
GTPases share high identity, suggesting common effector utilization; Ral effector orthologs
are also conserved in C. elegans. The strong conservation of the RalGEF effector pathway
components suggests an important role in C. elegans LET-60/Ras function.
RGL-1-RAL-1 Antagonizes Ras-Raf in Ras-mediated Vulval Development
Genetic dissection of LET-60/Ras signaling in vulval development was instrumental in
delineating the Raf-MEK-ERK pathway in mammalian cells. Consequently, we used
multiple genetic approaches to dissect the role of RGL-1 and RAL-1 in Ras-directed vulval
development. In a moderately activating gain-of-function (gf) LET-60 background (let-60
allele n1046; G13E mutation), we introduced rgl-1(RNAi) or ral-1(RNAi). Unexpectedly, we
found increased, rather than decreased, vulval hyper-induction (Figure 2C). Negative control
RNAi targeting gfp (green fluorescent protein) and lin-3 (encoding EGF, acting upstream)
had no effect, while positive control RNAi targeting gap-1 (encoding RasGAP, a negative
regulator of LET-60 activity) enhanced the let-60(gf) phenotype. rgl-1 or ral-1 knockdown
in a wild-type (WT) background caused no defect (data not shown), suggesting a
modulatory role for RGL-1-RAL-1 signaling.
A caveat is that the RGL-1/RAL-1-dependent phenotypes could be specific to
let-60(n1046gf), for example if the in situ activating mutation conferred inappropriate
LET-60/Ras utilization of RGL-1. We ruled out this concern by showing that rgl-1(RNAi)
and ral-1(RNAi) enhanced vulval hyper-induction due to LIN-3/EGF over-expression, an
activating LET-23/EGFR mutation, and a transgene expressing activated LIN-45/Raf, and
suppressed the under-induced phenotype conferred by reduced function mutations (rf) in
lin-3/EGF or let-23/EGFR (Figures S2A–E).
To corroborate these RNAi results with an independent methodology, we also analyzed a
ral-1 deletion (Δ), tm2760, which removes a portion of intron 3 including the splice donor
site. Presumably intron 3 splicing is blocked, resulting in strong loss of function. ral-1(Δ)
enhanced the let-60(gf) hyper-induced phenotype (Figure 2D).
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Dominant negative (dn) RAL-1(S31N), predicted to sequester and inactivate its GEF (Urano
et al., 1996), should also enhance activated LET-60-driven pro-1° activity. We generated
let-60(gf) animals harboring ral-1(dn) driven by the VPC-specific lin-31 promoter (Plin-31)
(Tan et al., 1998). The hyper-induced vulval phenotype of let-60(gf) animals expressing
RAL-1(dn) was enhanced compared to non-transgenic siblings (Figure 2E). In contrast,
VPC-specific expression of RAL-1(gf) (gain-of-function, Q75L) suppressed the hyper-
induced vulval phenotype of let-60(gf) animals relative to their non-transgenic siblings
(Figure 2F), while RAL-1(gf) caused no defect in a WT background (data not shown).
Control VPC-specific expression of WT RAL-1 did not alter the let-60(gf) phenotype,
indicating that our VPC expression system is phenotypically neutral (data not shown).
Taken together, these data support four conclusions. First, RGL-1 and RAL-1 antagonize the
canonical Ras-Raf-MEK-ERK pro-1° signal. Second, RGL-1 and RAL-1 function
comparably in vulval patterning and likely comprise a RGL-1-RAL-1 signaling module.
Third, RGL-1 and RAL-1 function cell autonomously in VPCs. Fourth, neither loss nor gain
of RGL-1 or RAL-1 function in a WT background perturbed vulval patterning, suggesting
that RGL-1 and RAL-1 are not part of core pro-1° or pro-2° induction pathways, but rather
are modifiers of LET-60/Ras stimulated vulval patterning signals. Other comparable
pathway modifiers, both positive and negative, have been identified in sensitized genetic
screens. Perturbation of these genes caused no phenotype alone, but collectively they exert a
profound influence on vulval patterning (Berset et al., 2001; Berset et al., 2005; Sundaram,
2006; Yoo et al., 2004; Yoo and Greenwald, 2005).
RAL-1 Contributes to the 1°/2° Fate Decision
To evaluate directly whether disruption of ral-1 perturbs cell fate specification, we used a
Pegl-17∷cfp-LacZ transgene as a reporter of 1° cell fate (Yoo et al., 2004). Notch-dependent
lateral signal normally prevents formation of neighboring 1° cells. However, when the 1°–2°
signaling balance is genetically disrupted to favor 1° fate, the frequency of neighboring 1°
lineages increases (Berset et al., 2001; Berset et al., 2005; Yoo et al., 2004). In a let-60(gf)
background, ral-1(RNAi) increased significantly the number of adjacent CFP-positive
lineages (Figures 3A–C and S3A–C). Because gfp-directed RNAi inhibits CFP expression,
daf-3(RNAi) rather than gfp(RNAi) was validated and used as a negative control (Figure
S3D). We conclude that RAL-1 activity promotes 2° fate at the expense of 1° fate, either
indirectly by antagonizing 1° fate, or directly by promoting 2° fate.
LET-60/Ras Mediates Genetically Separable Pro-1° and Antagonistic Signals
RGL-1 was identified previously in a yeast two-hybrid screen with activated LET-60 bait,
but further characterization was not pursued (Shibatohge et al., 1998). We hypothesize that
LET-60/Ras binds and activates RGL-1 to antagonize the Ras-Raf pro-1° signal, and thus
under certain conditions loss of LET-60/Ras should be functionally equivalent to loss of
RGL-1 and RAL-1. However, LET-60/Ras activation of LIN-45/Raf is an essential event
during vulval induction, so we could not directly assess the necessity of LET-60 for RGL-1
activation. To address this question we used hyper-inducing mutations in downstream genes,
thought to be independent of upstream Ras-Raf-MEK-ERK activity. In vulval induction the
principal pro-1° transcription factors are inhibited by ERK. Consequently, the lin-31(n301)
null mutation (“0”) and the lin-1(e1275ts) reduced function mutation (“rf”) confer moderate
hyper-induction. RNAi targeting lin-45/Raf and mpk-1/ERK had no effect on hyper-
induction, indicating that lin-31(0) and lin-1(rf) are Raf-MEK-ERK independent. lin-45/Raf
and mpk-1/ERK RNAi were validated separately for activity (Figures S3D–F and not
shown). In contrast RNAi of let-60, rgl-1 or ral-1 enhanced the lin-31(0) and lin-1(rf) hyper-
induced phenotypes (Figures 3D and 3E), suggesting that LET-60/Ras functions similarly to
RGL-1-RAL-1 in antagonizing Ras-Raf, and that this signal functions parallel to or
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downstream of LIN-31/LIN-1 transcription factors. We also repeated this result with
mutations; partial loss of let-60/Ras but not lin-45/Raf enhanced lin-31(0) (Figure 3F).
These data further suggest that in addition to the canonical pro-1° Ras signal through Raf-
MEK-ERK, Ras also signals through RGL-1-RAL-1 to antagonize Ras-Raf.
Ectopic LET-60/Ras Is Sufficient to Induce RGL-1-RAL-1 Activity
LET-60 shares 73–77% identity with human Ras proteins, with 100% identity in the core
effector-binding domain (32–40; Figure S1C). To assess whether Ras is sufficient to activate
RGL-1, we used mutationally activated LET-60 (let-60(12V)) with missense mutations that
result in differentially impaired effector binding. The E37G mutation retains effective
interaction with RalGEF but not Raf or PI3K, whereas the T35S mutation retains Raf but not
PI3K or RalGEF binding (Rodriguez-Viciana et al., 1997; White et al., 1995). We generated
otherwise WT animals harboring transgenes driving VPC-specific expression of let-60(12V)
(general gf) or let-60(12V,35S) (Raf gf). As expected, both transgenes caused a Raf-
dependent hyper-induced phenotype (Figures S3E and S3F). In contrast, transgenic VPC-
expressed let-60(12V,37G) (RalGEF gf) suppressed the hyper-induced phenotype of
let-60(gf) animals compared to non-transgenic siblings (Figure 3G), equivalent to the effect
of ral-1(gf) (above) and consistent with RalGEF-selective activity. Control VPC-specific
expression of let-60(+) in the let-60(gf) background caused no phenotype (data not shown).
While the H-Ras(12V,37G) effector-binding mutant is impaired in its ability to activate
PI3K and Raf, the mutant protein still retains the ability to bind other Ras-binding proteins
in addition to RalGEF (Kelley et al., 2001). However, we showed that the LET-60(12V,
37G) phenotype is entirely RGL-1- and RAL-1-dependent (Figure 3G), suggesting that the
LET-60(12V,37G) phenotype is not due to signaling through other effectors. Thus, we
conclude that Ras can signal through RalGEF in vulval fate specification.
In mammalian cells Ras is thought to be the exclusive small GTPase activator of RalGEFs,
but in Drosophila the Rap family of Ras-related small GTPases has been implicated in
RalGEF activation (Mirey et al., 2003; Rodriguez-Viciana et al., 2004). Our results argue
that in the vulva, it is Ras that signals through RalGEF, but we also tested vulval function of
characterized C. elegans Rap proteins. Injected rap-1(RNAi) or rap-2(RNAi) failed to
enhance the let-60(gf) phenotype (not shown), suggesting that Raps are not required for the
RGL-1-RAL-1 signal. Previously, RAL-1 was shown to function redundantly with the Rap
ortholog RAP-1 in essential epithelial morphogenesis, while loss of both rap-1 and rap-2 is
synthetic lethal (Frische et al., 2007; Pellis-van Berkel et al., 2005). For these reasons Raps
were not more extensively analyzed, but multiple lines of evidence argue that Ras activates
RGL-1-RAL-1 in vulval development as a bona fide vulval signaling module.
RAL-1 Cooperates with Notch to Specify 2° Vulval Fate
1° and 2° fates are mutually antagonistic, such that loss (or gain) of one pathway boosts (or
suppresses) the other. In this context there are two interpretations of our data thus far. First,
Ras-RalGEF-Ral could be an anti-1° pathway that impinges on the pro-1° pathway
downstream of the LIN-1 and LIN-31 transcription factors. Second, Ras-RalGEF-Ral could
function as an alternative signaling output of the EGF signal to promote 2° fate, thus finally
providing a mechanism for the morphogen gradient model. This second model is consistent
with the described mutual 1° vs. 2° antagonism in conjunction with our observations, as
follows. First, loss of a pro-2° signal (e.g. loss of rgl-1 and ral-1) should enhance the pro-1°
activity of let-60(gf). Second, activation of a pro-2° signal (e.g. ectopic activated RAL-1 or
RalGEF-selective Ras), should suppress the pro-1° activity of let-60(gf). Third, loss of a
pro-2° signal (e.g. loss of let-60, rgl-1 and ral-1) in the ERK-independent hyper-induced
transcription factor mutants should enhance their hyper-induced phenotypes. Therefore, we
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hypothesize that Ras-RalGEFRal promotes 2° fate, but our experiments thus far have only
examined Ras, RalGEF and Ral function in pro-1° assays.
To evaluate the second model we used sensitized dominant activated (d) LIN-12/Notch
backgrounds. lin-12(n302d) and lin-12(n379d) mutant animals have two features critical for
our study. First, they lack an AC, the source of EGF. Second, their activated pro-2° signal is
relatively weak, and thus sensitive to further stimulation (Greenwald et al., 1983).
Importantly, since there is no AC, the Notch activity assayed is likely to be LIN-3/EGF-
independent. VPC-specific expression of activated ral-1(gf) significantly enhanced lin-12(d)
excess 2° cell phenotypes (Figures 4A–C and S4A). Ectopic ral-1(gf) also enhanced
glp-1(q35d)/+ (Figure S4B); glp-1 encodes the second C. elegans Notch receptor (Mango et
al., 1991). RAL-1 is therefore sufficient to promote Notch pro-2° activity.
Additionally, expression of a RalGEF-selective LET-60(12V,37G) transgene, described
above, in the lin-12(n302d) background was sufficient to drive 2° fates, and this activity was
entirely rgl-1- and ral-1-dependent (Figure 4D). We note that as predicted from the 1° vs. 2°
mutual antagonism, LET-60(12V,37G) transgenes confer opposite effects in let-60(n1046gf)
pro-1° (Figure 3G) vs. lin-12(d) pro-2° backgrounds (Figure 4D). As an alternative test of
this same principle, we constructed a strain containing lin-12(n379d), let-60(n1046gf) and
the lin-45/Raf loss-of-function mutation, n2506. In this strain LET-60/Ras was active, but
Raf pro-1° signaling was abrogated. We observed strong Ras-dependent enhancement of the
lin-12(d) 2° induction, and this effect was significantly suppressed by ral-1(RNAi) (Figure
4E). Thus, Ras is sufficient to drive 2° fate, and Ras requires RalGEF and Ral for this
activity.
To determine whether RAL-1 is also necessary for LIN-12/Notch function, we used
ral-1(RNAi) in weakly activated lin-12(n302d) and lin-12(n379d) mutant animals, as well as
the moderately activating lin-12(n676d) and strongly activating lin-12(n950d) and
lin-12(n952d) mutant animals. In no case did we observe ral-1(RNAi) suppression of the
lin-12(d) excess 2° phenotype (data not shown). This result is expected if RAL-1 is required
only for the EGF pro-2° signal, and not the Notch pro-2° activity per se, and thus loss of
RAL-1 had no consequences in the absence of EGF signal.
To evaluate this model further we determined RAL-1 necessity for LIN-12/Notch pro-2°
function under EGF-dependent conditions. A lin-12/Notch hypomorphic allele (rf) confers
mildly compromised 2° induction, yet the AC is still present and a single vulval invagination
forms (Sundaram and Greenwald, 1993). In this background, ral-1(RNAi) caused modest but
significant losses of 2° lineages and increased morphogenetic defects (Figure 4F). We
propose that ral-1 is necessary for full LIN-12/Notch pro-2° activity, but only under EGF-
dependent conditions. Together, these observations suggest that Ras-RalGEF-Ral mediates
an EGF signal that promotes 2° fate, and we tested this hypothesis.
EGF Levels Insufficient for 1° Induction Can Induce 2° Fate through Ras and Ral
EGF was shown previously to be sufficient to induce 2° cells in the absence of neighboring
1° cells, arguing that there exists an EGF pro-2° signal (Katz et al., 1995; Katz et al., 1996;
Sternberg and Horvitz, 1986, 1989). To examine a putative RAL-1 function in propagating
the pro-2° EGF signal, we used two reagents to develop a robust EGF pro-2° signaling
assay. First, lin-12(n379d), described above, is a weakly activating Notch mutation that
abolishes AC development in ~90% of animals and weakly induces an ectopic 2° phenotype
(Greenwald et al., 1983). Second, to titrate EGF levels with temperature, we added to the
lin-12(d) background the temperature sensitive lin-15(n765ts) mutation, which at 15°C
caused no ectopic 1° induction but at 25°C is strongly hyper-induced via ectopic EGF
expression. lin-15 encodes components of a transcriptional regulatory complex that
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represses LIN-3/EGF expression outside of the AC, in the epithelia surrounding the VPCs
(Cui et al., 2006).
We compared the lin-12(d); lin-15(ts) double mutant to lin-12(d) and lin-15(ts) single
mutant strains from 15° to 18°C (Figure 5A). lin-12(d) is not temperature sensitive; at all
temperatures ~10% of animals had a normal AC/vulva and animals averaged ~0.4 ectopic
invaginations that we judged to be 2° based on morphological criteria (the distal 2° lineage
cells adhere to the cuticle, while the proximal cells invaginate) (Katz et al., 1995). In
lin-15(ts) single mutant animals, we observed no and rare ectopic vulval induction at 15°C
and 16°C respectively; however, since all animals had an AC they formed normal vulvae.
But lin-15(ts) ectopic induction greatly increased at 17°C and 18°C, and these invaginations
contained combined 1° and 2° lineages typical for ectopic pro-1° signaling. To better
contrast the lin-15(ts) single mutant ectopic pro-1° phenotype with the double mutant
lin-12(d); lin-15(ts) pro-2° phenotype, below, we show only ectopic pseudovulvae induced
in the lin-15(ts) single-mutant background, and excluded WT vulvae (Figure 5A, red).
Strikingly, in the double mutant strain we observed strong synergy at 15°C and 16°C
(P<0.00001 for both), temperatures at which lin-15(ts) alone was not sufficient to induce
ectopic 1° invaginations (Figure 5A). By morphology these excess invaginations were 2°,
indicating that sub-threshold EGF activity in a sensitized background induced large numbers
of 2° cells. To verify that the observed lin-15(ts) effect was EGF-dependent, we targeted
lin-3/EGF with RNAi and observed suppression of lin-15(ts) synergistic phenotypes (Figure
5B). Including the mgIs21 lin-11 promoter∷GFP fusion transgene in the lin-12(d); lin-15(ts)
strain as a reporter of 2° fate verified that these ectopically induced cells were mostly 2°
cells (Figure 5E and 5F). Thus we demonstrated that the putative EGF pro-2° signal
cooperates with the Notch pro-2° signal to specify 2° fate, a property predicted to increase
fidelity of vulval patterning. Furthermore, we have precisely controlled EGF input into 2°
fate induction.
A parsimonious working model posits that in presumptive 2° cells, EGF-activated Ras
signals preferentially through RGL-1 rather than Raf. A prediction of this model is that
LET-60/Ras and RAL-1 activity are necessary for full LIN-3/EGF pro-2° signaling output.
Our system for studying this EGF signaling property allowed us to analyze sufficient
numbers of animals to evaluate our model. We subjected lin-12(d); lin-15(ts) animals grown
at 16°C to let-60- (Figure 5B) or ral-1-directed RNAi (Figure 5C). Importantly, loss of both
let-60 and ral-1 suppressed the level of 2° hyper-induction, as did control loss of lin-12. As
an internal control for lin-12(RNAi) efficacy, we observed dramatic suppression of the
lin-12(d) absent-AC defect (from 13.2% with gfp(RNAi) to 76.5% with lin-12(RNAi)) (data
not shown).
We also performed lin-45(RNAi) in this background, and found that loss of LIN-45/Raf
enhanced 2° fate induction, consistent with the pro-1° function of Ras-Raf (Figure 5B). We
hypothesize that naïve presumptive 2° VPCs activate both Raf and RalGEF in response to
EGF signal, such that loss of the antagonistic Raf derepresses general pro-2° signaling.
To corroborate the lin-15 system we reproduced the lin-12(d); lin-15(ts) phenotype with an
activating mutation in LET-23/EGFR. Previously it was shown that let-23(sa62gf)/+ animals
induced 2° and 3° fate in isolated VPCs without an AC, while sa62/sa62 conferred mostly
1° fate (Katz et al., 1996). We found that let-23(sa62gf)/+; lin-12(n379d) had more 2° cells
than lin-12(n379d) alone, and this effect was suppressed by let-60(RNAi) or ral-1(RNAi)
(Figure 5D). Together, these data indicate that the Ras-RalGEF-Ral pathway mediates the
EGF pro-2° signal.
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Regulation of RAL-1 Expression Provides a Mechanism for Effector Switching
Transgenic embryos harboring a ral-1 promoter-driven gfp fusion construct showed broad
embryonic GFP expression. Post-embryonically, GFP was observed in excretory canals, a
small number of neurons, and was expressed dynamically in vulval lineages. Prior to EGF
induction, GFP was expressed in all VPCs, but at the time of induction GFP was restricted
to P5.p, P6.p and P7.p, cells receiving the EGF signal (Figures 6A and 6B). Soon thereafter
expression was extinguished in the presumptive 1° cell (P6.p), persisted strongly in
presumptive 2°s (P5.p and P7.p), and was faintly restored in presumptive 3°s (Figure 6C).
Further dynamic expression changes were seen in later vulval development, after fate
specification (Figure S5).
We show that LET-60/Ras switches effectors from pro-1° LIN-45/Raf output in presumptive
1° cells to pro-2° RGL-1-RAL-1 output in presumptive 2° cells. We hypothesize that the
mechanism of effector switching contains two components. First, RAL-1 expression
following initial induction is quickly restricted mainly to presumptive 2°s, and therefore
persistent Ras pro-2° signaling is limited to presumptive 2° cells. Second, concordant
restriction to presumptive 2° cells of LIP-1/ERK phosphatase quenches the ERK signal.
Thus, soon after initial induction the predominant Ras effector output in presumptive 2°
cells is RGL-1-RAL-1.
The early vulval RAL-1 expression pattern mirrors that of LIP-1 (Berset et al., 2001),
indicating that both RAL-1 and LIP-1 are precociously present to influence interpretation of
the initial EGF inductive signal to naïve VPCs. If so, in presumptive 1° cells the Ras-
RalGEF-Ral pro-2° response to EGF is expected to conflict with the Ras-Raf pro-1°
response. Likewise, in presumptive 1° cells the Ras-Raf pro-1° response should be blunted
by early LIP-1/ERK phosphatase expression. Therefore, rapid transcriptional exclusion of
both LIP-1 and RAL-1 proteins from the presumptive 1° cell facilitates maximal Ras-Raf
pro-1° activity. Supporting this model, rgl-1(RNAi) or ral-1(RNAi) suppressed the under-
induced phenotype conferred by reduced function mutations (rf) in lin-3/EGF or let-23/
EGFR (Figures S2D and S2E), and comparable suppression was observed with loss of LIP-1
(Berset et al., 2001). We argue that loss of RAL-1 or LIP-1 strengthens the initial pro-1°
inductive event in presumptive 1° cells, and thus rescues compromised EGF pro-1°
signaling. Hence, RAL-1 and LIP-1 cooperate as a programmed switch to toggle Ras output
from Raf to RGL-1 in presumptive 2° cells.
DISCUSSION
RGL-1-RAL-1 Provides a Mechanistic Key to Interpretation of the EGF Morphogen Gradient
The continually expanding number of functionally diverse effectors raises the issue of how
Ras signaling output is controlled through dynamic spatial and temporal effector utilization
to orchestrate its complex biology in normal and neoplastic cells. We describe mechanisms
whereby a balance of redirected effector signal output and pathway quenching can bring two
antagonistic pathways into harmony, with each faithfully promoting divergent fates in
response to the same initial patterning signal. This general patterning reinforcement/fidelity
mechanism may prove to be widespread in metazoan development.
The molecular mechanisms of EGF induction of 1° fate and consequent 1°-dependent Notch
induction of 2° fate are well characterized. Additionally, a graded EGF receptor signal has
been shown to exist, but direct EGF signaling from the AC is sufficient but not necessary for
2° fate induction (Koga and Ohshima, 1995; Simske and Kim, 1995). The mechanism by
which the pro-2° EGF receptor signal is propagated was previously unknown.
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We incorporate the insights from our study of Ral signaling into a new model in which we
reconcile prior models of graded morphogen signaling, sequential induction, and signal
quenching (Figure 7). We mechanistically validated the “graded morphogen model” and
show that Ras effector switching serves to emphasize the antagonistic relationship between
Ras and Notch. In the AC-proximal VPC (P6.p) EGF activates Ras and the ERK MAPK
cascade to induce 1° fate, which by stimulating production of Notch ligands in turn induces
2° fate in neighboring VPCs. In presumptive 2° cells the Raf pro-1° signal is rapidly
quenched by 2°-specific expression of LIP-1/ERK phosphatase (Berset et al., 2001) and
other negative regulators (Berset et al., 2005;Yoo et al., 2004;Yoo and Greenwald, 2005).
Instead, Ras signals through RGL-1 to promote 2° fate. Thus, the utilization of the RGL-1-
RAL-1 signaling module is a critical feature of the differential response of cells across the
EGF gradient. Such pathway interweaving may result in developmental fidelity and
robustness of vulval patterning (Braendle and Felix, 2008).
Loss of LET-60/Ras or RAL-1 suppressed the induction of 2° cells by lin-12(d); lin-15(ts) at
16°C and the induction of 2° cells by let-23(sa62gf)/+; lin-12(d), but only partially. We
therefore speculate that Ras-RGL-1-RAL-1 comprises only part of the pro-2° EGF signal.
We note that additional EGF pro-2° signaling activity may be Ras-independent, and is
perhaps engaged directly by activated EGF receptor.
Morphogen gradients have been studied for decades, yet there are still significant mysteries
in differential interpretation of signals across gradients (Lawrence, 2001). In other systems a
variety of gradient response mechanisms exist, from differential transcription of target genes
to signal-induced reprogramming of signal response (Ibanes and Izpisua Belmonte, 2008;
Piddini and Vincent, 2009), but correlation and causation are not always clear in these
systems. In cultured human cells exposed to ectopic EGF or heregulin ligand, downstream
pathway utilization varies dramatically by cell line, time of exposure, and ligand
concentration (Chen et al., 2009). In vulval patterning EGF gradient input is superimposed
on sequential EGF and Notch signals, and our results suggest that Ras effector switching
comprises a significant portion of EGF gradient interpretation.
Effector Switching Achieves Divergent Developmental Outcomes from the Same Signal
Our results indicate that Ras switches effector utilization between presumptive 1° and 2°
cells by restricting RAL-1 expression to presumptive 2° cells. It is unknown how this 2°-
specific RAL-1 transcriptional expression is patterned, but we hypothesize a combination of
ERK pro-1° and Notch pro-2° transcriptional outputs. However, unlike the promoters of 2°-
specific Notch-responsive lst genes, the promoter of ral-1 lacks concentrated conserved
Notch-responsive sequence elements (not shown). If past studies are an indicator, there are
likely to be multiple overlapping systems that cooperatively reprogram EGF output.
Clearly LIN-45/Raf effector pathway quenching is also critical, since there are significant
consequences of loss of LIP-1/ERK phosphatase (Berset et al., 2001). Based on our GFP
expression studies we speculate that a similar quenching phenomenon may exist for RAL-1
at the transcriptional level, since a ral-1 reporter is rapidly excluded from presumptive 1°
cells after initial induction. Thus RAL-1 quenching occurs in presumptive 1° cells and is
complementary to Ras-Raf-ERK quenching in presumptive 2° cells.
Theoretically, effector switching can also occur at the level of Ras effector binding. Loss of
the C. elegans SOC-2/SUR-8 (human Shoc2) diminishes Ras-Raf signaling (Selfors et al.,
1998; Sieburth et al., 1998). Shoc2 physically scaffolds Ras and Raf, thus regulating Ras-
Raf association and pathway activation (Li et al., 2000). Although no such protein has been
identified for Ras-RalGEF scaffolding, dynamic developmental regulation of such scaffolds
could critically impact effector usage.
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Previous studies of PC12 pheochromocytoma cell differentiation suggested that, via
differential effector usage, divergent developmental outcomes arise from a particular signal.
Nerve growth factor activation of Ras promotes Raf- and PI3K-dependent neuronal
differentiation and growth cessation (Jackson et al., 1996; Sano and Kitajima, 1998).
Conversely, Ras activation of RalGEF promotes proliferation and not differentiation (Goi et
al., 1999). Thus, Ras has the potential to promote both pro-differentiation and anti-
differentiation by engaging different effectors in the same cell type. In PC12 cells, RalGEF
is speculated to be eventually uncoupled from Ras (Goi et al., 1999). Thus, while the
potential for effector switching has been demonstrated in cell culture, mechanisms of
pathway interaction are lacking.
The Ras-RalGEF parallelism to Ras-Raf was foreshadowed by a previous Drosophila study
(Karim and Rubin, 1998). Also in Drosophila, activated Ras phenotypes were enhanced by a
Ral dominant negative, consistent with the antagonistic Ras-Raf and Ras-RalGEF activities
described here (Mirey et al., 2003). The use of multiple Ras effectors in parallel in the same
developmental event may explain these puzzling results, or the relationship amongst Ras,
Ral and Rap small GTPases may be different in different developmental contexts.
Interplay between Notch and Ras signaling is a common theme in developmental biology,
and Notch and Ras interplay is also observed in mouse pancreatic cell differentiation and
cancer development (Mysliwiec and Boucher, 2009; Sundaram, 2005). Whether this
pancreatic Ras-Notch interplay depends on K-Ras activation of the RalGEF-Ral pathway is
not known, but it is intriguing that RalGEF but not Raf is preferentially activated in
pancreatic cancer cells and Ral activation is necessary for pancreatic cancer growth (Lim et
al., 2005; Lim et al., 2006).
Efforts to develop anti-Ras inhibitors have focused on targeting effector signaling (Yeh and
Der, 2007), and have been complicated by cell- and cancer-type differences in effector
dependency and activation (Hamad et al., 2002; Lim et al., 2005; Rangarajan et al., 2004;
Tuveson et al., 2004). How differential effector utilization and activation is achieved
remains an unresolved issue. Our observations establish one mechanism for this
phenomenon. Additional mechanisms may involve regulation of the subcellular localization
of Ras to distinct membrane compartments, leading to spatial regulation of effector
activation (Bivona et al., 2006; Onken et al., 2006).
In conclusion, we demonstrate a patterning role for Ras effector switching that has
implications beyond developmental genetics. Studies in model genetic organisms in
conjunction with mouse and cell culture studies were instrumental in developing our early
understanding of key signal transduction pathways, including canonical EGF signaling
through the Ras-Raf-MEK-ERK signaling module to regulate transcription. Recent studies
in pathway quenching, and now effector switching, to promote alternative ligand outputs
argue that C. elegans vulval patterning continues to yield important insights into diverse
biological fields.
EXPERIMENTAL PROCEDURES
General C. elegans Methods, Strains, Constructs and Transgenic Lines
Strain handling and generation of constructs and transgenic lines used standard methods, see
Supplemental Data.
ral-1(tm2760); let-60(n1046gf) Double Mutant Construction
The ral-1(tm2760) deletion, kindly provided by Shohei Mitani, removes nucleotides 418–
996 (numbered from position +1 of the ral-1 initiating ATG codon), deleting part of the
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splice donor site. Single worm PCR of ral-1(tm2760) was performed as described (Williams
et al., 1992). In the initial strain isolate, heterozygous tm2760 co-segregated with a sterile
mutation. Outcrossing tm2760 and recombination in the daf-2-dpy-17 interval failed to
separate the sterile mutation from tm2760. ral-1(RNAi) did not impact fertility, even when
performed in the eri-1(mg366) RNAi hypersensitive background (Kennedy et al., 2004).
Therefore, we hypothesize that sterility is conferred by a mutation closely linked to
ral-1(tm2760). Sterile animals formed a functional vulva, so in the let-60(n1046gf)
background we balanced ral-1(tm2760) with unc-93(e1500sd) dpy-17(e164). We used the
semi-dominant unc-93(e1550sd) Unc phenotype to distinguish tm2760/tm2760
homozygotes from tm2760/unc-93 dpy-17 heterozygotes, and scored vulvas of non-Unc
animals. Single worm PCR (Tm=53°, cycles=35) with the primers TZ23
(CAACAAGTCGTCCATAAAGTG), TZ24 (GGCGAAAAACGAGAAAAGAAC), and
TZ25 (GAATTTTTCAGGCTTTCTGACG) confirmed the tm2760/tm2760 genotype of
each scored animal.
Bacterially Mediated RNA interference
Bacterially mediated RNAi was performed mostly as described (Fire et al., 1998; Kamath et
al., 2001; Timmons et al., 2001). Each feeding RNAi (fRNAi) clone was sequenced to
confirm identity. Eighty μl of bacteria was seeded on NGM agar plates containing 1 mM
IPTG and 50 μg/ml carbenicillin. L4 larvae were added to the plates the following day. After
24 h, animals were transferred to new plates, and parents were removed after an additional
24 h. We consistently obtained stronger fRNAi phenotypes at 23°C, and thus all fRNAi
experiments were performed at 23°C. gfp(RNAi) or daf-3(RNAi) was used as a control.
pop-1(RNAi) was included in all experiments as a positive control for RNAi efficacy.
Phenotypes were only scored if we observed 100% lethality on the pop-1(RNAi) plates.
Vulval Induction Assay
Late L4 hermaphrodites were mounted as described previously in 5 mM sodium azide/M9
buffer on slides with agar pads. L4 vulval invaginations were visualized under DIC
Nomarski optics (Sternberg and Horvitz, 1986; Sulston and Horvitz, 1977). Images were
captured using a Nikon Eclipse E800 microscope with a Hamamatsu C2400-07 Newvicon
camera controlled by Metamorph acquisition software (Molecular Devices). WT animals
scored 3.0 (3 induced VPCs). Values greater than 3.0 indicated hyper-induction, less than
3.0 under-induction.
Fluorescence Microscopy
Live animals were mounted in 2 mg/ml tetramisole/M9 buffer on slides with agar pads and
visualized using a Nikon Eclipse TE2000U microscope equipped with a DVC-1412 CCD
camera (Digital Video Camera Company) controlled by the Hamamatsu SimplePCI
acquisition software.
HIGHLIGHTS
• Ras-RalGEF-Ral indirectly antagonizes Ras-Raf pro-1° vulval fate induction.
• The Ras-RalGEF-Ral signaling module cooperates with Notch to specify 2°
fate.
• The EGF pro-2° signal is transduced in part by Ras-RalGEF-Ral.
• Induction restricts Ral expression to presumptive 2° vulval precursor cells.
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Figure 1. An Overview of VPC Patterning
(A) A graded EGF signal from the anchor cell (AC) induces vulval fates. High EGF levels
(black arrow) activate the EGFR-Ras-Raf pathway in P6.p to induce 1° fate. Lateral signal
(gray arrows) from the presumptive 1° cell activates LIN-12/Notch in P5.p and P7.p to
induce 2° fate. 1° and 2° descendents form the vulva; 3° VPCs are non-vulval. Low EGF
levels (dashed arrows) may help pattern P5.p and P7.p.
(B) The EGF-Ras-MAP kinase signal transduction pathway specifies 1° cell fate.
(C) Sequence alignment of Homo sapiens (H.s.) RalA and RalB, Drosophila melanogaster
(D.m.) Ral, and Caenorhabditis elegans (C.e.) RAL-1. Identical and similar residues are
marked with black and grey shading, respectively. Residues S31 (mutated to N for dn) and
Q75 (mutated to L for gf) are shown by arrows. The core effector domain is boxed in solid
lines, and the C-terminal hypervariable and CAAX prenylation signal motif region in dashed
lines. Accession numbers for RGL-1 and RAL-1 are NP_001123140 and NP_497689,
respectively. See also Figure S1.
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Figure 2. RAL-1 Antagonizes LET-60-dependent Vulval Induction
(A and B) DIC micrographs of (A) wild type and (B) let-60(n1046gf); gfp(RNAi) animals as
late L4 larvae. Bars indicate the typical 2°-1°-2° vulva, and the arrow indicates a
pseudovulva. Anterior is left and ventral down.
(C) rgl-1(RNAi) or ral-1(RNAi) enhanced let-60(n1046gf) hyper-induction. Negative
controls were gfp(RNAi) and lin-3/EGF(RNAi), and the positive control was gap-1/
RasGAP(RNAi). Data shown are representative of six independent assays.
(D) The ral-1 deletion, tm2760, enhanced let-60(n1046gf). The n1046 single mutant was
counted in nine assays, the double mutant in four.
(E) Transgenic dominant-negative RAL-1(S31N) enhanced let-60(gf). Two transgenes were
analyzed; that shown was assayed three times, another four.
(F) Transgenic activated RAL-1(Q75L) suppressed let-60(gf). One transgene was assayed
seven times.
Y-axis is the number of VPCs induced to vulval (1° and 2°) fates. Data are the mean ±
standard error of the mean (SEM). For statistical reasons single, non-pooled assays are
shown, and white numbers represent animals scored therein. Statistics were calculated by
Kruskal-Wallis, Dunn test (C) or Mann-Whitney test (D–F).
See also Figure S2.
Zand et al. Page 17













Figure 3. Ras-RGL-1-RAL-1 Bypasses Ras-Raf to Control Cell Fate
(A and B) Expression of Pegl-17∷cfp-lacZ in VPC daughters. Overlaid DIC and CFP
fluorescence images of (A) let-60(n1046gf); daf-3(RNAi) and (B) let-60(gf); ral-1(RNAi) at
the Pn.px stage. The black bar indicates P6.px and white bar indicates P7.px cells.
(C) Percent L3 larvae with CFP-positive lineages neighboring the P6.p lineage (P5.p or P7.p
derived) at the Pn.px stage in the let-60(gf); arIs92 (Pegl-17∷cfp-lacZ) background. Shown
are average percentages of animals with adjacent 1° cell fate from three independent assays
± SEM. The numbers of adjacent 1° cells out of the total per assay were, for daf-3(RNAi)
3/25, 6/26, and 6/30, for ral-1(RNAi) 17/27, 19/29, and 18/30, and for lin-12(RNAi) 12/17
and 20/28. White numbers represent pooled total animals scored.
(D) let-60-, rgl-1-, and ral-1-directed RNAi enhanced the hyper-inducing lin-31(n301). gfp,
gap-1, lin-45, and mpk-1 RNAi controls were negative. Data shown are representative of
three independent assays.
(E) lin-12-, let-60-, rgl-1-, and ral-1-directed RNAi enhanced the hyper-inducing
lin-1(e1275ts) at 23°C. gfp, gap-1, lin-45, and mpk-1 RNAi controls were negative. Data
shown are representative of three independent assays.
(F) let-60(n2021rf) but not lin-45(sy96rf) enhanced the hyper-inducing lin-31(n301). Data
shown are representative of four independent assays.
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(G) Transgenic activated LET-60(12V, 37G) (RalGEF selective) suppressed let-60(n1046gf)
compared to non-transgene bearing siblings, and was RGL-1 and RAL-1 dependent. Two
transgenes were assayed three times each.
Y-axis is the number of VPCs induced to vulval (1° and 2°) fates. Data are the mean ± SEM.
For statistical reasons single, non-pooled assays are shown, and white numbers represent
animals scored therein. Statistics were calculated by Fisher's Exact Test (C) or Kruskal-
Wallis, Dunn test (D–G).
See also Figure S3.
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Figure 4. Ras-RalGEF-Ral Promotes Pro-2° Fate
(A and B) DIC micrographs of late L4 stage (A) lin-12(n302d) and (B) lin-12(n302d) +
ral-1(Q75L) animals. Arrows indicate ectopic 2° cells. Anterior is left and ventral is down.
(C) Transgenic activated RAL-1(Q75L) enhanced 2° cell induction of activated
lin-12(n302d). Two transgenes were assayed four times each.
(D) Transgenic activated LET-60(12V,37G) (RalGEF selective) enhanced lin-12(n302d)
compared to non-transgene bearing siblings, and was RGL-1 and RAL-1 dependent. Two
transgenes were assayed three times each.
(E) Endogenous activated LET-60 (let-60(n1046gf)) with blocked LIN-45/Raf
(lin-45(n2506rf)) enhanced lin-12(n379d), and was RAL-1-dependent. Data shown are
representative of three independent assays.
Y-axis is the number of VPCs induced to vulval (1° and 2°) fates (C and D) or total vulval
invaginations (E). Data are the mean ± SEM. For statistical reasons single non-pooled assays
are shown, and white numbers represent animals scored therein.
(F) The lin-12(n137n460rf) temperature sensitive hypomorph is sensitive to loss of RAL-1.
ral-1(RNAi) caused significant loss of 2° lineages and increased incidence of
morphologically abnormal vulvae. We observed double 2° loss in ral-1(RNAi) but not
gfp(RNAi) controls, and thus loss of ral-1 was qualitatively different. Results are from three
pooled assays (*p<0.05, **p<0.01, ****p<0.0001).
Statistics were calculated by Mann-Whitney test (C), Kruskal-Wallis, Dunn test (D and E) or
Fisher's Exact test (F).
See also Figure S4.
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Figure 5. ral-1-dependent EGF and EGFR Signaling is Sufficient for Pro-2° Activity
(A) A comparison of lin-12(n379d) alone (black bars), lin-12(n379d); lin-15(n765ts) (gray
bars) and lin-15(n765ts) alone (red bars), all grown on gfp(RNAi). Animals were grown at
15°, 16°, 17° or 18°C. Total vulval invaginations (left, black Y axis for black and gray
columns), or ectopic pseudovulval invaginations (right, red Y axis for red columns) were
scored.
(B) RNAi of lin-3/EGF, let-60/Ras or lin-12/Notch suppressed invaginations induced by
lin-12(n379d); lin-15(n765ts) at 16°C, and lin-45(RNAi) enhanced. Data shown are
representative of three independent assays.
(C) ral-1(RNAi) or lin-12(RNAi) suppressed invaginations induced by lin-12(n379d);
lin-15(n765ts) at 16°C. Data shown are representative of three independent assays.
(D) Activated let-23(sa62gf)/+ (moderately activated EGFR) enhanced invaginations
induced by lin-12(n379d) in a LET-60- and RAL-1-dependent manner. Data shown are
representative of three independent assays.
Y-axis is the number of total vulval invaginations at 16°C (B and C) or 23°C (D). Data are
the mean ± SEM. For statistical reasons single, non-pooled assays are shown, and white
numbers represent animals scored therein. Statistics were calculated by Mann-Whitney test
(A) or Kruskal-Wallis, Dunn test (B–D).
(E and F) Ectopic vulval cells induced at 16°C by lin-15(ts) in the lin-12(n379d) background
are 2°. (E) DIC and (F) epifluorescent images of mgIs21(Plin-11∷gfp+rol-6(d));
Zand et al. Page 21













lin-12(n379d); lin-15(n765ts). 19/20 ectopically induced VPCs expressed the lin-11 2° fate
marker.
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Figure 6. Pral-1∷gfp is Dynamically Expressed During Early Vulval Development
Before induction Pral-1∷gfp (NLS+) is expressed in all VPCs, but first is restricted to EGF-
induced presumptive 1° and 2° VPCs, and then to 2° cells only. (A) Early Pn.p stage before
induction. (B) Mid Pn.p stage. The background glow is strong excretory canal expression.
The P7.p nucleus was GFP-positive, but was out of the plane of focus. (C) Late Pn.p stage
with absent P6.p expression.
See also Figure S5.
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Figure 7. EGF Signaling through Ras Uses Effector Switching to Induce Opposing Vulval Fates
Signal promoting both fates is shown in green, pro-1° signal in blue, pro-2° signal in red,
and quenched signals in gray. A putative EGF concentration gradient, in combination with
sequential induction, faithfully patterns vulval fates. In presumptive 1° cells EGF activates
Ras to utilize Raf to promote 1° cell fate. Pro-2° signaling through Notch is quenched.
Putative quenching of RGL-1-RAL-1 pro-1° activity is based on RAL-1 exclusion from
presumptive 1° cells. Presumptive 1° cells produce DSL ligands to induce neighboring
VPCs via Notch to assume 2° fate. In presumptive 2° cells, Notch induces production of
LIP-1/ERK phosphatase and other 2°-specific proteins to quench the Raf pro-1° signal.
Also, EGF activates Ras to utilize RGL-1-RAL-1 to promote 2° fate. Thus, the EGF signal
toggles its developmental output by Ras effector switching.
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